CLOUDCLUSTER

Amgen Looking Attractive Heading into Earnings

yoy: I completely agree. Amgen is in major overbought territory, perhaps the most ever in its history. At this point I feel Nplate + an earnings beat on Monday is priced in. MACD, RSI, CCI, MA, whatever technical indicator you want to look at... they're screaming sell/buy protection. It's inevitable that the market pauses for a retracement back to the 50 day.